Indication

Idiopathic parkinsonism

Idiopathic parkinsonism, commonly referred to as idiopathic Parkinson disease, is a chronic, progressive neurodegenerative movement disorder of unknown etiology primarily affecting the central nervous system in older adults. Read more about Idiopathic parkinsonism

735 drugs 257 manufacturers

Advertisement

Drugs that treat it

Common Idiopathic parkinsonism therapies.

Showing 307–315 of 735 drugs

BENZTROPINE MESYLATE

ANTIPARKINSONIAN ANTICHOLINERGIC AGENTS·PARKINSONISM·+4
GSK Consumer Healthcare
Filter & compare in the drug finder →Opens the drug finder with Idiopathic parkinsonism preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Idiopathic parkinsonism.

Idiopathic parkinsonism, commonly referred to as idiopathic Parkinson disease, is a chronic, progressive neurodegenerative movement disorder of unknown etiology primarily affecting the central nervous system in older adults.

It is pathologically characterized by the degeneration of dopaminergic neurons within the substantia nigra pars compacta and the abnormal intraneuronal accumulation of alpha-synuclein into Lewy bodies.

Clinically, the condition is defined by asymmetric motor manifestations—most notably bradykinesia combined with resting tremor, cogwheel rigidity, and postural instability—often accompanied by nonmotor features such as autonomic dysfunction, sleep disturbances, and cognitive changes.

Personalize your experience

Follow Idiopathic parkinsonism and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it